Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Taniguchi

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Infection and Drug Resistance|October 24, 2018
Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumoniaDaisuke Kobayashi, Yuichiro Shindo, Ryota Ito, et al.
Pulmonary Medicine|June 4, 2011
Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosisMasahito Ebina, Hiroyuki Taniguchi, Taku Miyasho, et al.
Bioorganic & Medicinal Chemistry|June 26, 2019
Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moietyYuuki Koizumi, Yoshihito Tanaka, Takehiko Matsumura, et al.
Respirology (Carlton, Vic.)|August 9, 2017
Disease severity staging system for idiopathic pulmonary fibrosis in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Kensuke Kataoka, et al.
The Clinical Respiratory Journal|November 26, 2015
Analysis of the relationship between health status and mortality in hypercapnic patients with noninvasive ventilationToru Oga, Hiroyuki Taniguchi, Hideo Kita, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2010
Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II studyMotoshi Ichikawa, Ryujiro Suzuki, Kensuke Kataoka, et al.
The European Respiratory Journal|December 16, 2014
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisTakashi Ogura, Hiroyuki Taniguchi, Arata Azuma, et al.
Radiology|March 26, 2014
Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT patternHiromitsu Sumikawa, Takeshi Johkoh, Kiminori Fujimoto, et al.
Canadian Respiratory Journal|June 8, 2017
Comparison of Different Disease-Specific Health-Related Quality of Life Measurements in Patients with Long-Term Noninvasive VentilationToru Oga, Hiroyuki Taniguchi, Hideo Kita, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2007
Computed tomography findings in pathological usual interstitial pneumonia: relationship to survivalHiromitsu Sumikawa, Takeshi Johkoh, Thomas V Colby, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Infection and Drug Resistance|October 24, 2018
Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumoniaDaisuke Kobayashi, Yuichiro Shindo, Ryota Ito, et al.
Pulmonary Medicine|June 4, 2011
Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosisMasahito Ebina, Hiroyuki Taniguchi, Taku Miyasho, et al.
Bioorganic & Medicinal Chemistry|June 26, 2019
Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moietyYuuki Koizumi, Yoshihito Tanaka, Takehiko Matsumura, et al.
Respirology (Carlton, Vic.)|August 9, 2017
Disease severity staging system for idiopathic pulmonary fibrosis in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Kensuke Kataoka, et al.
The Clinical Respiratory Journal|November 26, 2015
Analysis of the relationship between health status and mortality in hypercapnic patients with noninvasive ventilationToru Oga, Hiroyuki Taniguchi, Hideo Kita, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2010
Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II studyMotoshi Ichikawa, Ryujiro Suzuki, Kensuke Kataoka, et al.
The European Respiratory Journal|December 16, 2014
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisTakashi Ogura, Hiroyuki Taniguchi, Arata Azuma, et al.
Radiology|March 26, 2014
Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT patternHiromitsu Sumikawa, Takeshi Johkoh, Kiminori Fujimoto, et al.
Canadian Respiratory Journal|June 8, 2017
Comparison of Different Disease-Specific Health-Related Quality of Life Measurements in Patients with Long-Term Noninvasive VentilationToru Oga, Hiroyuki Taniguchi, Hideo Kita, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2007
Computed tomography findings in pathological usual interstitial pneumonia: relationship to survivalHiromitsu Sumikawa, Takeshi Johkoh, Thomas V Colby, et al.
Pageof 18